{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:23:33Z","timestamp":1791876213367,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Auckland Doctoral Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00415-015-7869-2","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T07:32:22Z","timestamp":1438414342000},"page":"2457-2465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression"],"prefix":"10.1007","volume":"262","author":[{"given":"Hannah M.","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean H.","family":"Kilfoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"issue":"5","key":"7869_CR1","first-page":"359","volume":"19","author":"SE Purdon","year":"1994","unstructured":"Purdon SE, Mohr E, Ilivitsky V, Jones BD (1994) Huntington\u2019s disease: pathogenesis, diagnosis and treatment. J Psychiatry Neurosci 19(5):359\u2013367","journal-title":"J Psychiatry Neurosci"},{"issue":"20","key":"7869_CR2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","volume":"315","author":"JB Martin","year":"1986","unstructured":"Martin JB, Gusella JF (1986) Huntington\u2019s disease. Pathogenesis and management. N Engl J Med 315(20):1267\u20131276","journal-title":"N Engl J Med"},{"key":"7869_CR3","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group and The Hungtinton Study Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s disease collaborative research group. Cell 72(6):971\u201383","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"1","key":"7869_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC et al (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1\u201314","journal-title":"Neuropsychology"},{"issue":"4","key":"7869_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","volume":"25","author":"AD Ha","year":"2012","unstructured":"Ha AD, Fung VSC (2012) Huntington\u2019s disease. Curr Opin Neurol 25(4):491\u2013498","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"7869_CR6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000227890.87398.c1","volume":"67","author":"T Blekher","year":"2006","unstructured":"Blekher T, Johnson SA, Marshall J, White K, Hui S, Weaver M et al (2006) Saccades in presymptomatic and early stages of Huntington disease. Neurology 67(3):394\u2013399","journal-title":"Neurology"},{"issue":"3","key":"7869_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00221-007-1248-x","volume":"186","author":"A Peltsch","year":"2008","unstructured":"Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz DP (2008) Saccadic impairments in Huntington\u2019s disease. Exp Brain Res 186(3):457\u2013469","journal-title":"Exp Brain Res"},{"issue":"3","key":"7869_CR8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.38.3.427","volume":"38","author":"AG Lasker","year":"1988","unstructured":"Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington\u2019s disease: slowing and dysmetria. Neurology 38(3):427\u2013431","journal-title":"Neurology"},{"issue":"10","key":"7869_CR9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.33.10.1268","volume":"33","author":"RJ Leigh","year":"1983","unstructured":"Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington\u2019s disease. Neurology 33(10):1268\u20131275","journal-title":"Neurology"},{"issue":"2","key":"7869_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrneurol.2012.273","volume":"9","author":"TJ Anderson","year":"2013","unstructured":"Anderson TJ, MacAskill MR (2013) Eye movements in patients with neurodegenerative disorders. Nat Rev Neurol 9(2):74\u201385","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"7869_CR11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","volume":"31","author":"RE Sakai","year":"2011","unstructured":"Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31(4):362\u2013373","journal-title":"J Neuroophthalmol"},{"issue":"5035","key":"7869_CR12","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al (1991) Optical coherence tomography. Science 254(5035):1178\u20131181","journal-title":"Science"},{"issue":"11","key":"7869_CR13","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1364\/OPEX.12.002404","volume":"12","author":"M Wojtkowski","year":"2004","unstructured":"Wojtkowski M, Srinivasan VJ, Ko TH, Fujimoto JG, Kowalczyk A, Duker JS (2004) Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express 12(11):2404\u20132422","journal-title":"Opt Express"},{"issue":"2","key":"7869_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","volume":"116","author":"O Altintas","year":"2008","unstructured":"Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease. Doc Ophthalmol 116(2):137\u2013146","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"7869_CR15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","volume":"113","author":"JB Fisher","year":"2006","unstructured":"Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML et al (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113(2):324\u2013332","journal-title":"Ophthalmology"},{"issue":"16","key":"7869_CR16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","volume":"69","author":"E Gordon-Lipkin","year":"2007","unstructured":"Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ et al (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69(16):1603\u20131609","journal-title":"Neurology"},{"issue":"3","key":"7869_CR17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1756285610368890","volume":"3","author":"BM Greenberg","year":"2010","unstructured":"Greenberg BM, Frohman E (2010) Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord 3(3):153\u2013160","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"7869_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18\u201324","journal-title":"J Neuroophthalmol"},{"issue":"3","key":"7869_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.0b013e31827deb39","volume":"80","author":"A Klistorner","year":"2013","unstructured":"Klistorner A, Garrick R, Barnett MH, Graham SL, Arvind H, Sriram P et al (2013) Axonal loss in nonoptic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Neurology 80(3):242\u2013245","journal-title":"Neurology"},{"issue":"3","key":"7869_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WNO.0b013e31829c510e","volume":"33","author":"AP Lange","year":"2013","unstructured":"Lange AP, Sadjadi R, Zhu F, Alkabie S, Costello F, Traboulsee AL (2013) Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients. J Neuroophthalmol 33(3):213\u2013219","journal-title":"J Neuroophthalmol"},{"issue":"12","key":"7869_CR21","doi-asserted-by":"crossref","first-page":"e113936","DOI":"10.1371\/journal.pone.0113936","volume":"9","author":"S Llufriu","year":"2014","unstructured":"Llufriu S, Sepulveda M, Blanco Y, Marin P, Moreno B, Berenguer J et al (2014) Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. Plos One 9(12):e113936","journal-title":"Plos One"},{"issue":"10","key":"7869_CR22","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1167\/iovs.08-1815","volume":"49","author":"H Merle","year":"2008","unstructured":"Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P (2008) Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 49(10):4412\u20134417","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"7869_CR23","first-page":"680","volume":"28","author":"V Polo","year":"2014","unstructured":"Polo V, Garcia-Martin E, Bambo MP, Pinilla J, Larrosa JM, Satue M et al (2014) Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer\u2019s disease. Eye (Basingstoke) 28(6):680\u2013690","journal-title":"Eye (Basingstoke)"},{"issue":"4","key":"7869_CR24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2013.4","volume":"27","author":"M Satue","year":"2013","unstructured":"Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R et al (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients. Eye 27(4):507\u2013514","journal-title":"Eye"},{"issue":"1","key":"7869_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","volume":"8","author":"KM Galetta","year":"2011","unstructured":"Galetta KM, Calabresi PA, Frohman EM, Balcer LJ (2011) Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 8(1):117\u2013132","journal-title":"Neurotherapeutics"},{"issue":"12","key":"7869_CR26","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mds.23816","volume":"26","author":"R Reilmann","year":"2011","unstructured":"Reilmann R, Bohlen S, Kirsten F, Ringelstein EB, Lange HW (2011) Assessment of involuntary choreatic movements in Huntington\u2019s disease\u2013toward objective and quantitative measures. Mov Disord 26(12):2267\u20132273","journal-title":"Mov Disord"},{"issue":"5","key":"7869_CR27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41(5):689\u2013692","journal-title":"Ann Neurol"},{"issue":"6","key":"7869_CR28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrneurol.2014.79","volume":"10","author":"HM Kersten","year":"2014","unstructured":"Kersten HM, Roxburgh RH, Danesh-Meyer HV (2014) Ophthalmic manifestations of inherited neurodegenerative disorders. Nat Rev Neurol 10(6):349\u2013362","journal-title":"Nat Rev Neurol"},{"issue":"Pt 1","key":"7869_CR29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","volume":"132","author":"F Fortuna","year":"2009","unstructured":"Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C et al (2009) Visual system involvement in patients with Friedreich\u2019s ataxia. Brain 132(Pt 1):116\u2013123","journal-title":"Brain"},{"issue":"3","key":"7869_CR30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11910-012-0260-0","volume":"12","author":"KS Sitarz","year":"2012","unstructured":"Sitarz KS, Chinnery PF, Yu-Wai-Man P (2012) Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets. Curr Neurol Neurosci Rep 12(3):308\u2013317","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"7869_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","volume":"112","author":"P Barboni","year":"2005","unstructured":"Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM et al (2005) Retinal nerve fiber layer evaluation by optical coherence tomography in Leber\u2019s hereditary optic neuropathy. Ophthalmology 112(1):120\u2013126","journal-title":"Ophthalmology"},{"issue":"Pt 10","key":"7869_CR32","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","volume":"135","author":"S Klebe","year":"2012","unstructured":"Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P et al (2012) Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy. Brain 135(Pt 10):2980\u20132993","journal-title":"Brain"},{"issue":"3","key":"7869_CR33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0032-1329198","volume":"32","author":"J Li","year":"2012","unstructured":"Li J (2012) Inherited neuropathies. Semin Neurol 32(3):204\u2013214","journal-title":"Semin Neurol"},{"key":"7869_CR34","first-page":"223","volume":"98","author":"AA Sadun","year":"2000","unstructured":"Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V (2000) Leber\u2019s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 98:223\u2013232","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"7869_CR35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90(3):905\u2013981","journal-title":"Physiol Rev"},{"issue":"7","key":"7869_CR36","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA et al (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20(7):1438\u20131455","journal-title":"Hum Mol Genet"},{"issue":"11","key":"7869_CR37","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J et al (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28(11):2783\u20132792","journal-title":"J Neurosci"},{"issue":"4","key":"7869_CR38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ (2010) The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 55(4):299\u2013334","journal-title":"Surv Ophthalmol"},{"issue":"26","key":"7869_CR39","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","volume":"11","author":"D Helmlinger","year":"2002","unstructured":"Helmlinger D, Yvert G, Picaud S, Merienne K, Sahel J, Mandel J-L et al (2002) Progressive retinal degeneration and dysfunction in R6 Huntington\u2019s disease mice. Hum Mol Genet 11(26):3351\u20133359","journal-title":"Hum Mol Genet"},{"issue":"4","key":"7869_CR40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410340411","volume":"34","author":"W Paulus","year":"1993","unstructured":"Paulus W, Schwarz G, Werner A, Lange H, Bayer A, Hofschuster M et al (1993) Impairment of retinal increment thresholds in Huntington\u2019s disease. Ann Neurol 34(4):574\u2013578","journal-title":"Ann Neurol"},{"issue":"5","key":"7869_CR41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-005-1092-7","volume":"110","author":"E Petrasch-Parwez","year":"2005","unstructured":"Petrasch-Parwez E, Saft C, Schlichting A, Andrich J, Napirei M, Arning L et al (2005) Is the retina affected in Huntington disease? Acta Neuropathol 110(5):523\u2013525","journal-title":"Acta Neuropathol"},{"issue":"2","key":"7869_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cne.20327","volume":"479","author":"E Petrasch-Parwez","year":"2004","unstructured":"Petrasch-Parwez E, Habbes H-W, Weickert S, Lobbecke-Schumacher M, Striedinger K, Wieczorek S et al (2004) Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington\u2019s disease. J Comp Neurol 479(2):181\u2013197","journal-title":"J Comp Neurol"},{"issue":"3","key":"7869_CR43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.nbd.2011.12.004","volume":"45","author":"AH Batcha","year":"2012","unstructured":"Batcha AH, Greferath U, Jobling AI, Vessey KA, Ward MM, Nithianantharajah J et al (2012) Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6\/1 mouse model of Huntington\u2019s disease. Neurobiol Dis 45(3):887\u2013896","journal-title":"Neurobiol Dis"},{"issue":"2","key":"7869_CR44","doi-asserted-by":"crossref","first-page":"e56026","DOI":"10.1371\/journal.pone.0056026","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Yasumura D, Ma AAK, Matthes MT, Yang H, Nielson G et al (2013) Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease. Plos One 8(2):e56026","journal-title":"Plos One"},{"issue":"12","key":"7869_CR45","doi-asserted-by":"crossref","first-page":"e113317","DOI":"10.1371\/journal.pone.0113317","volume":"9","author":"S Ragauskas","year":"2014","unstructured":"Ragauskas S, Leinonen H, Puranen J, Ronkko S, Nymark S, Gurevicius K et al (2014) Early retinal function deficit without prominent morphological changes in the R6\/2 mouse model of Huntington\u2019s disease. Plos One 9(12):e113317","journal-title":"Plos One"},{"issue":"7","key":"7869_CR46","first-page":"561","volume":"15","author":"K Mizuno","year":"1976","unstructured":"Mizuno K, Asaoka M (1976) Cycloscopy and fluorescein cycloscopy. Investig Ophthalmol 15(7):561\u2013564","journal-title":"Investig Ophthalmol"},{"issue":"12","key":"7869_CR47","first-page":"1520","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AFD, Biglan KM et al (2013) Natural history of Huntington disease. JAMA Neurol 70(12):1520\u20131530","journal-title":"JAMA Neurol"},{"key":"7869_CR48","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group and The Hungtinton Study Group (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Huntington Study Group. Mov Disord 11(2):136\u201342","DOI":"10.1002\/mds.870110204"},{"issue":"Suppl 1","key":"7869_CR49","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00702-013-1037-6","volume":"120","author":"A Stroet","year":"2013","unstructured":"Stroet A, Linker RA, Gold R (2013) Advancing therapeutic options in multiple sclerosis with neuroprotective properties. J Neural Transm 120(Suppl 1):S49\u2013S53","journal-title":"J Neural Transm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7869-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:10:44Z","timestamp":1567037444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["7869"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7869-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}